Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy

Author： Billheimer J.T.   He B.   Spitz S.M.   Stern A.M.   Seiffert D.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.107, Iss.6, 2002-09, pp. : 303-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monitoring the effects of platelet glycoprotein IIb/IIIa antagonists with a microtiter plate method for detection of platelet aggregation

By Krause Siegfried   Scholz Thomas   Temmler Uta   Lösche Wolfgang  

Platelets, Vol. 12, Iss. 7, 2001-11 ,pp. : 423-430

Informa Healthcare

Access to resources Recommend Favorite

Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists

By Sirotkina Olga   Khaspekova Svetlana   Zabotina Anna   Shimanova Yulia   Mazurov Alexey  

Platelets, Vol. 18, Iss. 7, 2007-11 ,pp. : 506-514

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists Inhibit the Development of Platelet Procoagulant Activity - Partial mapping of functionally significant glycoprotein IIIa epitopes

By Pedicord D.L.   Thomas B.E.   Mousa S.A.   Dicker I.B.  

Thrombosis Research, Vol. 90, Iss. 6, 1998-06 ,pp. : 247-258

Elsevier

Access to resources Recommend Favorite

Effect of Glycoprotein IIb/IIIa Antagonists on the HIT Serum Induced Activation of Platelets

By Jeske W.P.   Walenga J.M.   Szatkowski E.   Ero M.   Herbert J.M.   Haas S.   Bakhos M.  

Thrombosis Research, Vol. 88, Iss. 3, 1997-11 ,pp. : 271-281

Elsevier

Access to resources Recommend Favorite

Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist

By Seiffert Dietmar   Thomas Beth E.   Bradley Jodi D.   Munzer Deborah A.   Tchinnes Maureen A.   Kornhauser David M.   Cain Valerie A.   Hua Tsuhung A.   Feuerstein Giora Z.   Martin David E.   Stern Andrew M.  

Platelets, Vol. 14, Iss. 3, 2003-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite